Before intervention (95% CI)* | ||||||||
---|---|---|---|---|---|---|---|---|
Penicillin-V | Amoxicillin | Amoxicillin-Clavulanic acid | Macrolide | Quinolone | Tetracycline | Cephalosporin | Other | |
Argentina | 4.2 (1.6-6.9) | 52.6 (38.6-66.7) | 24.5 (13.8-35.2) | 9.7 (5.5-14.0) | 1.6 (0-3.5) | 0 (0-0) | 4.6 (1.1-8.2) | 10.3 (1.3-19.3) |
Denmark | 60.0 (55.3-65.7) | 13.6 (10.0-17.2) | 1.3 (0-2.9) | 23.1 (17.6-28.5) | 0.8 (0-1.8) | 1.0 (0-2.4) | 0 (0-0) | 0.8 (0-1.6) |
Lithuania | 6.9 (1.7-12.2) | 33.4 (21.9-44.9) | 25.4 (17.3-33.5) | 19.7 (14.8-24.7) | 1.7 (0.3-3.1) | 1.8 (0.3-3.5) | 10.7 (3.6-17.9) | 1.3 (0-2.6) |
Russia | 4.7 (0.4-9.1) | 33.7 (24.1-43.4) | 28.0 (17.1-38.9) | 13.8 (5.8-21.7) | 4.7 (0-9.5) | 0.4 (0-1.0) | 20.2 (13.1-27.2) | 0.8 (0-1.7) |
Spain | 0.2 (0-0.5) | 19.3 (15.8-22.8) | 44.9 (40.7-49.1) | 13.5 (10.6-16.4) | 16.0 (12.9-19.1) | 0.4 (0-0.9) | 3.6 (2.3-5.0) | 2.5 (0.6-4.3) |
Sweden | 30.1 (19.2-40.9) | 14.2 (8.0-20.3) | 0 (0-0) | 6.2 (1.9-10.4) | 0 (0-0) | 48.7 (39.1-58.3) | 1.8 (0-4.1) | 0 (0-0) |
After intervention (95% CI)* | ||||||||
Argentina | 3.3 (0.5-6.2) | 35.5 (26.3-44.6) | 34.6 (25.4-43.8) | 19.4 (9.8-29.0) | 2.4 (0-5.3) | 0.9 (0-1.8) | 4.9 (0.4-9.4) | 21.4 (2.0-40.9) |
Denmark | 70.7 (65.7-75.8) | 10.8 (6.7-14.9) | 6.2 (3.4-9.0) | 11.1 (8.2-14.1) | 0 (0-0) | 0.2 (0-0.5) | 0 (0-0) | 0.9 (0-1.8) |
Lithuania | 38.1 (25.1-51.0) | 22.9 (13.8-32.1) | 6.1 (0.2-12.0) | 22.1 (14.3-29.9) | 0 (0-0) | 3.0 (0.9-5.2) | 5.2 (2.0-8.4) | 3.4 (0-7.7) |
Russia | 10.7 (1.8-19.4) | 47.9 (35.0-60.7) | 17.9 (8.1-27.8) | 6.4 (1.9-10.9) | 2.5 (0-5.2) | 0 (0-0) | 15.8 (6.7-24.9) | 0.4 (0-1.3) |
Spain | 0.5 (0-1.0) | 22.5 (18.0-27.0) | 42.8 (37.7-48.0) | 12.9 (9.7-16.0) | 16.1 (12.7-19.4) | 0 (0-0) | 3.9 (2.0-5.9) | 1.8 (0.9-2.8) |
Sweden | 43.5 (29.8-57.3) | 10.6 (3.3-17.9) | 0 (0-0) | 5.9 (1.5-10.2) | 0 (0-0) | 37.6 (23.5-51.8) | 0 (0-0) | 2.3 (0-5.6) |